Efficient Synthesis and In Vitro Hypoglycemic Activity of Rare Apigenin Glycosylation Derivatives
Molecules · 05.01.2023 · 28 (2) · 533
DOI: 10.3390/molecules28020533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 05.01.2023. Verfasst von Lin Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM …. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Apigenin. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Nanjing University of Chinese Medicine Youth Foundation, Young Talent Support Project of Jiangsu Provincial Association for Science and Technology.
Abstract (Originalsprache)
Apigenin is a natural flavonoid with significant biological activity, but poor solubility in water and low bioavailability limits its use in the food and pharmaceutical industries. In this paper, apigenin-7-O-β-(6″-O)-d-glucoside (AG) and apigenin-7-O-β-(6″-O-succinyl)-d-glucoside (SAG), rare apigenin glycosyl and succinyl derivatives formed by the organic solvent-tolerant bacteria Bacillus licheniformis WNJ02 were used in a 10.0% DMSO (v/v) system. The water solubility of SAG was 174 times that of apigenin, which solved the application problem. In the biotransformation reaction, the conversion rate of apigenin (1.0 g/L) was 100% at 24 h, and the yield of SAG was 94.2%. Molecular docking showed that the hypoglycemic activity of apigenin, apigenin-7-glucosides (AG), and SAG was mediated by binding with amino acids of α-glucosidase. The molecular docking results were verified by an in vitro anti-α-glucosidase assay and glucose consumption assay of active compounds. SAG had significant anti-α-glucosidase activity, with an IC50 of 0.485 mM and enhanced glucose consumption in HepG2 cells, which make it an excellent α-glucosidase inhibitor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Jiangsu Key Laboratory for High Technology Research of TCM Formulae, Crich, 138 Xianlin Road, Nanjing 210023, China.
Förderung
- National Natural Science Foundation of China
- Nanjing University of Chinese Medicine Youth Foundation
- Young Talent Support Project of Jiangsu Provincial Association for Science and Technology
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
Zitieren
APA
Zhao, L., Pei, Y., Zhang, G., Li, J., Zhu, Y., Xia, M., Yan, K., Mu, W., Han, J., Zhang, S., & Duan, J. (2023). Efficient Synthesis and In Vitro Hypoglycemic Activity of Rare Apigenin Glycosylation Derivatives. Molecules, 28(2), 533. https://doi.org/10.3390/molecules28020533
Vancouver
Zhao L, Pei Y, Zhang G, Li J, Zhu Y, Xia M, et al. Efficient Synthesis and In Vitro Hypoglycemic Activity of Rare Apigenin Glycosylation Derivatives. Molecules. 2023;28(2):533. doi:10.3390/molecules28020533
BibTeX
@article{Zhao2023,
author = {Zhao, Lin and Pei, Yuqiong and Zhang, Guoxin and Li, Jiayao and Zhu, Yujie and Xia, Mingjun and Yan, Ke and Mu, Wen and Han, Jing and Zhang, Sen and Duan, Jinao},
title = {Efficient Synthesis and In Vitro Hypoglycemic Activity of Rare Apigenin Glycosylation Derivatives},
journal = {Molecules},
year = {2023},
volume = {28},
number = {2},
pages = {533},
doi = {10.3390/molecules28020533}
}
EUVIMED